Followers | 34 |
Posts | 2049 |
Boards Moderated | 0 |
Alias Born | 12/03/2013 |
Tuesday, November 25, 2014 8:59:08 AM
So we just got a commitment from Merck to supply their anti-PD1 drug at NO CHARGE for a Phase 2b...the first combination therapy with anti-PD1 in EVER in the history of the world....and we have to get these details from our f*cking CEO on twitter and through his blog? While obviously a full fledged partnership with cash would be ideal, this is still great news yet the PR lacks so many details.
People on here are wondering whether this is for the Phase 2b, which Punit's blog confirms. They are wondering who is paying, well Punit clarified that over twitter. Great, thanks for including that in the PR....
The headline is just so exciting..."ONCS collaborates with UCSF", really? I get that there are probably a lot of restrictions in how much they can say and use Merck's name but they completely screwed the pooch in terms of delivering the key details and expressing the SIGNIFICANCE of this event.
If I had never heard of ONCS and I came across this PR it wouldn't have me all that excited. However had it said that "ONCS is embarking on the first ever combination study with an anti-PD1 together with Merck" perhaps I'd get excited.
Sorry for the rant guys, obviously I'm thrilled as to what this means for the big picture but in my opinion ONCS once again let's us down with their ability to communicate to the market.
Recent ONCSQ News
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/13/2024 07:30:19 PM
HealthLynked Corp. Announces Second Quarter and First Half 2024 Results: Continued Cost Reductions Set the Stage for Strategic Shift to App-Based Technology Services • HLYK • Aug 16, 2024 8:00 AM
PickleJar Announces Official Name Change and New Ticker Symbol • NREG • Aug 15, 2024 2:23 PM
VAYK's Q2 Profit Added to Accumulated Net Profit of Over $2.2 Million In 18 Months • VAYK • Aug 15, 2024 9:07 AM
Swifty Global Reports Strong Q2 Performance and Prepares for Major Exchange Uplisting • DRCR • Aug 15, 2024 9:04 AM
Mayback's Global Entertainment Signs Global Distribution Agreement with Children's Media Studio • AHRO • Aug 15, 2024 8:45 AM
POET Technologies Reports Second Quarter 2024 Financial Results • POET • Aug 15, 2024 8:04 AM